Description
LL-37 is a naturally occurring 37-amino-acid peptide derived from the human cathelicidin precursor protein hCAP18. It is studied in experimental settings involving innate immune signaling, peptide–membrane interactions, microbial response mechanisms, inflammatory pathways, cellular communication, and other areas of molecular and biochemical research.
Although LL-37 has been evaluated in preclinical research, this material is not an FDA-approved drug product and should not be represented as a treatment for infections, wound healing, inflammation, immune disorders, or any other human condition. For Research Use Only. Not for human or veterinary use, ingestion, administration, diagnostic procedures, or therapeutic applications.
Additional information
| Concentration | 5mg, 10mg |
|---|



Reviews
There are no reviews yet.